Jushi Holdings Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

ACQUISITIONS - Narrative (Details)

ACQUISITIONS - Narrative (Details)					1 Months Ended				3 Months Ended		6 Months Ended
ACQUISITIONS - Narrative (Details)	Jun. 30, 2022 USD ($)	Sep. 10, 2021 USD ($) ft² dispensary $ / shares shares	Apr. 30, 2021 USD ($)	Mar. 04, 2021 USD ($) $ / shares shares	Jul. 31, 2022 USD ($) shares	Apr. 30, 2022 USD ($) $ / shares shares	Mar. 31, 2022 USD ($) $ / shares shares	Jul. 31, 2021 USD ($) ft²	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Sep. 09, 2022	Dec. 31, 2021 USD ($)	Jul. 31, 2021 a
Business Acquisition [Line Items]
Change in contingent consideration									$ (1,081,000)	$ 0	$ (676,000)	$ 0
Contingent consideration liabilities - current portion	$ 8,560,000								8,560,000		8,560,000			$ 0
Acquisition and deal costs									1,161,000	$ 870,000	1,302,000	$ 1,109,000
Contingent consideration liabilities - non-current	7,043,000								7,043,000		7,043,000			8,223,000
OhiGrow Assets Acquisition
Business Acquisition [Line Items]
Area of real estate property (in sq ft)								10,000							1.35
Consideration paid in cash, as adjusted for working capital adjustments								$ 4,949,000
Grover Beach Assets Acquisition
Business Acquisition [Line Items]
Consideration paid in cash, as adjusted for working capital adjustments				$ 3,592,000
Equity acquired				78.00%
Equity interest issued and issuable (in shares) \| shares				49,348
Equity issued, price per share (in dollars per share) \| $ / shares				$ 7.46
Rights to remaining equity				$ 1
Grover Beach Assets Acquisition \| Subsequent Event
Business Acquisition [Line Items]
Equity acquired													22.00%
NuLeaf
Business Acquisition [Line Items]
Equity interests acquired						100.00%
Equity issued (in shares) \| shares						4,662,384
Equity issued, price per share (in dollars per share) \| $ / shares						$ 2.91
Debt instrument term						5 years
Consideration payable in cash (customary hold back)						$ 1,000,000
Contingent liability						10,000,000
Contingent liability, cash						3,000,000
Contingent liability, additional debt						3,000,000
Change in contingent consideration	1,326,000
Contingent consideration liabilities - current portion	6,731,000					8,057,000			6,731,000		6,731,000
Consideration paid in cash, as adjusted for working capital adjustments						$ 14,850,000
NuLeaf \| Subsequent Event
Business Acquisition [Line Items]
Debt instrument term					5 years
Payment for contingent consideration liability					$ 3,000,000
Equity interest issued to settle contingent liability (in shares) \| shares					888,880
Apothecarium
Business Acquisition [Line Items]
Equity interests acquired							100.00%
Equity issued (in shares) \| shares							527,704
Equity issued, price per share (in dollars per share) \| $ / shares							$ 3.02
Debt instrument term							5 years
Consideration payable in cash (customary hold back)							$ 0
Contingent consideration liabilities - current portion							0
Consideration paid in cash, as adjusted for working capital adjustments							6,617,000
Consideration paid in promissory notes (fair value)							9,853,000
Minimum contingent consideration							0
Maximum contingent consideration							2,000,000
Apothecarium \| Maximum
Business Acquisition [Line Items]
Contingent liability							$ 2,000,000
Apothecarium and NuLeaf
Business Acquisition [Line Items]
Acquisition and deal costs									1,109,000		1,260,000
Contributed revenues									9,008,000		9,564,000
Contributed net income									(740,000)		(811,000)
Nature's Remedy
Business Acquisition [Line Items]
Equity interests acquired		100.00%
Upfront cash consideration		$ 40,360,000
Equity issued (in shares) \| shares		8,700,000
Equity issued, price per share (in dollars per share) \| $ / shares		$ 4.10
Contingent liability	8,871,000	$ 8,223,000							8,871,000		8,871,000			$ 8,223,000
Contingent consideration liabilities - current portion	1,828,000								1,828,000		1,828,000
Minimum contingent consideration		0
Maximum contingent consideration		$ 10,800,000
Number of retail dispensaries \| dispensary		2
Area of real estate property (in sq ft) \| ft²		50,000
Contingent consideration, equity interest issued and issuable		$ 5,000,000
Contingent consideration liabilities - non-current	$ 7,043,000								$ 7,043,000		$ 7,043,000
Nature's Remedy \| First Milestone Period
Business Acquisition [Line Items]
Contingent consideration period		12 months
Nature's Remedy \| Second Milestone Period
Business Acquisition [Line Items]
Contingent consideration period		18 months
Nature's Remedy \| Nature's Remedy Three-Year Note
Business Acquisition [Line Items]
Debt instrument term		3 years
Contingent liability, additional debt		$ 5,000,000
Consideration paid in promissory notes (fair value)		$ 11,500,000
Nature's Remedy \| Nature's Remedy Five-Year Note
Business Acquisition [Line Items]
Debt instrument term		5 years
Consideration paid in promissory notes (fair value)		$ 5,000,000
Organic Solutions of the Desert, LLC
Business Acquisition [Line Items]
Equity interests acquired			100.00%
Upfront cash consideration			$ 1,827,000
Consideration paid in promissory notes (fair value)			$ 3,100,000